USNA — Stock Film
STOCK FILMSCENE 1/11USNA · $15.02
Stock Expert AI presents
USNA
USANA Health Sciences, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
USANA Health Sciences, Inc. What it actually does.

Develops and manufactures science-based nutritional supplements. Offers a range of vitamin and mineral supplements for various age groups. Now — the numbers.

on the stock market since 1994
1,570 employees
$277.3M market value
Revenue last year:
$925.3M
The net profit left over:
$10.8M
Out of every $100 in sales, $1 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 1%

This is an established company with proven profits.

Cash on hand:
$158.4M
Total debt:
$14M
The cash outweighs the debt.

If every debt were paid off today, $144.4M would still be left in the vault — a solid cushion for hard times.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
25.8×

The market pays 25.8× for every dollar of annual profit — around what a business like this usually costs.

Against companies in its own sector, it looks cheaper than 87% of them.

Analysts' average target sits 133% above today's price.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
53
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
87
very strong

Debt is low and cash is strong; the finances stand solid.

VALUATION
87
very strong

The price looks reasonable next to what the company earns.

GROWTH
30
very weak

Clearly below the class average.

PRICE MOMENTUM
20
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 5 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
A strong cash pile8/10
The shares trade freely10/10
WEAK SPOTS
The stock has lost its spark3/10
Sales are shrinking4/10
WORTH WATCHING

Revenue Growth: Sales are going backwards, not just slowing.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 86% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Strong cash, light debt

There is $158.4M in the vault; even if every debt were paid off, $144.4M would remain.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 5 years, sales fell about 5% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 20/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 30/100.

FINALE · THE GRADE
B+
61 / 100 · MoonshotScore

On our five-subject report card, USNA sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: USNA is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film